Artivion to Participate in Upcoming Investor Conferences

AORT 11.05.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-19
Name of Upcoming Event:Stifel 2024 Healthcare Conference
Date of Upcoming Event:2024-11-21
Name of Upcoming Event:Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Full Press ReleaseSEC FilingsOur AORT Tweets

About Gravity Analytica

Recent News

  • 12.09.2024 - Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
  • 11.19.2024 - Stifel 2024 Healthcare Conference
  • 11.07.2024 - Q3 2024 Artivion, Inc. Earnings Conference Call

Recent Filings

  • 12.23.2024 - 8-K Current report
  • 12.13.2024 - 4 Statement of changes in beneficial ownership of securities
  • 12.12.2024 - 144 Report of proposed sale of securities

ATLANTA,Nov. 5, 2024/PRNewswire/ --Artivion, Inc.(NYSE: AORT),a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion'smanagement team will present at the upcoming Stifel 2024 Healthcare Conference onTuesday, November 19, 2024, at theLotte New York Palace. The Company's presentation is scheduled to begin at1:15p.m. ET. A live webcast can be accessed throughArtivion'swebsite,www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.

Members of the management team will also host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics andDigital Health & Services ForumonThursday, November 21, 2024, inNew York. Due to the format of this event no webcast will be available.

AboutArtivion, Inc.Headquartered in suburbanAtlanta, Georgia,Artivion, Inc.is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases.Artivion'sfour major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues.Artivionmarkets and sells products in more than 100 countries worldwide. For additional information aboutArtivion, visit our website,www.artivion.com.

Contacts:

Artivion

Gilmartin Group LLC

Lance A. Berry

Brian Johnston/Laine Morgan

Executive Vice President &

Phone: 332-895-3222

Chief Financial Officer

investors@artivion.com

Phone: 770-419-3355

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302296852.html

SOURCEArtivion, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com